Is it a good company at a reasonable price? Even though this stock has not done much in Stock Price over the past 5 years, I still like this stock. It generally has good growth. It is a small cap and I did buy it with my fooling around money. I plan to hold on to the stock I have. Currently the stock price seems to be on the cheap side.
I own this stock of Jamieson Wellness Inc (TSX-JWEL, OTC-JWLLF). This stock was written up in November 26, 2020 by Kay Ng on Motley Fool. She looked at what Warren Buffet was buying and pick some similar stocks, including Jamieson from TSX. I am buying Jamison because it is cheap and I think that it will do well in the future. It has only been on the stock market for 8 years. However, the dividend increases are good. I understand the risks I am taking. I bought this with my fooling around money.
When I was updating my spreadsheet, I noticed all the officer I follow bought more stock last year. This includes the CFO and CFO. One of the directors I follow also bought more shares. Ink shows lots of selling, but it is just officers and directors not picking up options.
If you had invested in this company in July 17, 2017, for $1,003.40 you would have bought 58 shares at $17.30 per share. In December 2025, after just over some 8 years you would have received $273.76 in dividends. The stock would be worth $1,951.70. Your total return would have been $2,225.46. This would be a total return of 9.87% per year with 8.18% from capital gain and 1.69% from dividends.
| Cost | Tot. Cost | Shares | Years | Dividends | Stock Val | Tot Ret |
|---|---|---|---|---|---|---|
| $17.30 | $1,003.40 | 58 | 8.46 | $273.76 | $1,951.70 | $2,225.46 |
The current dividend yield is moderate with dividend growth moderate. The current dividend yield is moderate (2% to 4% ranges) at 2.19%. The 5 year median dividend yield is moderate at 2.31%. The 8 year and historical median dividend yield is low (below 2%) at 1.64% and 1.64%. The dividends have been increased at a moderate level (8% to 14% ranges) at 13.3% per year over the past 5 years. The last dividend increase was in 2025 and it was for 9.5%.
The Dividend Payout Ratios (DPR) are good. The DPR for 2025 for Earnings per Share (EPS) is high at 60% with 5 year coverage at 58%. The DPR for 2025 for Adjusted Earnings per Share (AEPS) is good at 47% with 5 year coverage at 45%. DPRs in the 40% range is probably the best. The DPR for 2025 for Cash Flow per Share (CFPS) is good at 36% with 5 year coverage at 37%. This DPR below at 40% or lower is good. The DPR for 2025 for Free Cash Flow (FCF) is good at 43% with 5 year coverage at 44%. The FCF for 2025 range from $69.8M to $86.9M. I am using the $86.9M value.
| Item | Cur | 5 Years |
|---|---|---|
| EPS | 60.27% | 57.62% |
| AEPS | 47.57% | 45.33% |
| CFPS | 36.32% | 36.61% |
| FCF | 42.81% | 44.39% |
Debt Ratios are fine. The Long Term Debt/Market Cap Ratio for 2025 is good at 0.20 and currently at 0.30. The Liquidity Ratio for 2025 is good at 1.53 and 1.59 currently. The Debt Ratio for 2025 is good at 1.83 and 1.77 currently. The Leverage and Debt/Equity Ratios for 2025 are fine at 2.39 and 1.31 and currently at 2.50 and 1.41.
| Type | Year End | Ratio Curr |
|---|---|---|
| Lg Term R | 0.20 | 0.30 |
| Intang/GW | 0.43 | 0.46 |
| Liquidity | 2.53 | 2.59 |
| Liq. + CF | 2.69 | 2.86 |
| Debt Ratio | 1.83 | 1.77 |
| Leverage | 2.39 | 2.50 |
| D/E Ratio | 1.31 | 1.41 |
The Total Return per Year is shown below for years of 5 to 9 to the end of 2025. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.
| Years | Div. Gth | Tot Ret | Cap Gain | Div. |
|---|---|---|---|---|
| 5 | 13.36% | 0.63% | -1.41% | 2.04% |
| 8.46 | 14.55% | 9.87% | 8.18% | 1.69% |
The 5-year low, median, and high median Price/Earnings per Share Ratios are 25.84, 28.51 and 31.18. The corresponding 8 year and historical ratios are 23.77, 28.51 and 32.95. The current ratio is 19.61 based on EPS of $2.14 and a stock price of $41.96. The current ratio is below the low ratios of the 8 year median ratios. This stock price testing suggests that the stock price is relatively cheap.
I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 20.22, 21.52 and 23.92. The corresponding 9 year and historical ratios are 20.70, 22.99 and 27.46. The current ratio is 19.61 based on AEPS of $2.14 and a stock price of $41.96. The current ratio is below the low ratios of the 8 year median ratios. This stock price testing suggests that the stock price is relatively cheap.
I get a Graham Price of $23.91. The 9-year low, median, and high median Price/Graham Price Ratios are 1.70, 1.88 and 2.20. The current ratio is 1.76 based on a stock price of $41.96. The current ratio is between the low and median ratios of the 9 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.
I get a 9-year median Price/Book Value per Share Ratio of 3.33. The current ratio is 3.53 based on a Book Value of $492M, Book Value per Share of $11.87 and a stock price of $41.96. The current ratio is 6% above the 9 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median.
I also have a Book Value per Share estimate for 2026 of $14.43. This gives a ratio of 2.90 based on a Book Value of $600M, Book Value per Share of $14.43 and a stock price of $41.96. The ratio is 13% below the 9 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.
I get a 9-year median Price/Cash Flow per Share Ratio of 32.52. The current ratio is 20.77 based Cash Flow per Share estimate for 2026 of $2.02, Cash Flow of $83.8M and a stock price of $41.96. The current ratio is 36% below the 9 year median ratio. This stock price testing suggests that the stock price is relatively cheap.
I get an historical and 9 year median dividend yield of 1.64%. The current dividend yield is 2.19% based on dividends of $0.92 and a stock price of $41.96. The current dividend yield is 34% above the historical and 9 yar median dividend yield. This stock price testing suggests that the stock price is relatively cheap.
The 9-year median Price/Sales (Revenue) Ratio is 2.48. The current P/S Ratio is 1.89 based on Revenue estimate for 2026 of $919M, Revenue per Share of $22.16 and a stock price of $41.96. The current ratio is 24% below the 9 year median ratio. This stock price testing suggests that the stock price is relatively cheap.
Results of stock price testing is that the stock price is probably cheap. The 9 year median dividend yield test says this and it is confirmed by the P/S Ratio test. The other tests vary from cheap to reasonable but above the median.
When I look at analysts’ recommendations, I find Strong Buy (4), and Buy (3). The consensus would be a Strong Buy. The 12 month consensus stock price is $46.21 with a high of $51.00 and low of $44.00. The consensus stock price of $46.21 implies a total return of 12.32% with 10.13% from capital gains and 2.19% from dividends based on a current stock price of $41.96.
For 2025 on Stock Chase there is a Top Pick, Buy, Watch and Hold recommendations. A positive that is mentioned is that it is growing in China due to attention to quality. Daniel Da Costa on Motley Fool this is stock is a defensive growth stock. Adam Othman on Motley Fool thinks this stock is a cheap growth stock. The company put out Press Release about their fourth quarter of 2025. The company put out a press release via Businesswire about their first quarter of 2026 results.
This article on The Canadian press via Yahoo Finance says that the company is in talks about an offer to buy the company. Personally, I hope that is not bought. Simply Wall Street via Yahoo Finance reviews this stock and think that it is undervalued. They like the fact it went from an earnings loss of $0.06 to earnings of $0.23.
Jamieson Wellness Inc is engaged in the manufacturing, development, distribution, and marketing of branded natural health products, including vitamins, minerals, and supplements. Geographically, the majority of its revenue is derived from the domestic market. Its web site is here Jamieson Wellness Inc.
The last stock I wrote about was about was Premium Brands Holdings Corp (TSX-PBH, OTC-PRBZF) ... learn more. The next stock I will write about will be Suncor Energy Inc (TSX-SU, NYSE-SU) ... learn more on Wednesday, July 15, 2026 around 5 pm. Tomorrow on my other blog I will write about Bill Ackman by Robin Speziale.... learn more on Tuesday, July 14, 2026 around 5 pm.
This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.
See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.